How to Treat Biliary Tract Cancer – Treatment Algorithm with Dr. Suneel Kamath

In this episode of the Oncology Brothers, we welcomed Dr. Suneel Kamath from the Cleveland Clinic to discuss the complex landscape of biliary tract cancer. While this cancer type is not the most common, it carries a poor prognosis, making it crucial for oncologists to stay informed about the latest treatment options.

Listen us on:

Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966

Follow us on social media:

• ⁠X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/

Join us as we explored:

• The role of surgery and adjuvant chemotherapy in early-stage biliary tract cancer.
• Frontline treatment strategies for metastatic disease, including insights from the TOPAZ-1 and KEYNOTE-966 studies.
• The importance of biomarker testing, including HER2, IDH1, and FGFR mutations, and how they influence treatment decisions.
• Management of side effects associated with various therapies, including immunotherapy and chemotherapy.
• The emerging landscape of targeted therapies and the need for more effective treatment options.

Whether you're a medical professional or someone interested in oncology, this episode provides valuable insights into the current treatment algorithms and challenges in managing biliary tract cancer.

Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!

#BiliaryTractCancer, #Cholangiocarcinoma, #Immunotherapy, #BiomarkerTesting, #OncologyBrothers